References: Update on toxicity and efficacy aspects of treatment with deferasirox and its implication on the morbidity and mortality of transfused iron loaded patients

112

Views

CrossRef citations to date

Altmetric

Bibliography

Kontoghiorghes GJ: Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities. Expert Opin Drug Saf 2007;6:235-9
PubMed Web of Science ®Google Scholar
Anonymous: Deferasirox: for iron overload: only a third-line option. Prescrire Int 2007;16(91):196
Google Scholar
Maggio A. Light and shadows in the iron chelation treatment of haematological diseases. Br J Haematol 2007;138:407-21
PubMed Web of Science ®Google Scholar
Kontoghiorghes GJ. Ethical issues and risk/benefi t assessment on iron chelation therapy: advances with deferiprone/deferoxamine combination and concerns about the safety, effi cacy and costs of deferasirox. Hemoglobin 2008;32:1-15
PubMed Web of Science ®Google Scholar
Anonymous. Treating the kidney to treat the heart. Product CMX001 (deferiprone). Available from: http://www.cormedix.com
Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Update on toxicity and efficacy aspects of treatment with deferasirox and its implication on the morbidity and mortality of transfused iron loaded patients

Bibliography

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Update on toxicity and efficacy aspects of treatment with deferasirox and its implication on the morbidity and mortality of transfused iron loaded patients

Bibliography

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date